An unusual presentation of Sweet syndrome in a patient with ulcerative
colitis treated with a tumor necrosis factor alpha inhibitor: a case
Tumor necrosis factor (TNF) alpha inhibitors are widely used to treat
inflammatory bowel disease (IBD) and Sweet syndrome is known as an
extra-intestinal cutaneous manifestation of IBD. We wish to highlight a
paradoxical case and successful management of anti-TNF-agent-induced
Sweet syndrome compared with Sweet syndrome treated by anti-TNF agents.